PCSK9 and cirrhosis of liver: Patients with liver cirrhosis under vasopressor therapy had 162.4 (44.7–641.2) ng/mL, while those without had 111.3 (59.0–173.6) ng/mL PCSK9 in plasma, and this difference was determined to be significant (Table 2).